Levels of markers in blood and EBC in pneumoconioses

D. Pelclova, Z. Fenclova, M. Krmencikova, T. Navratil, M. Kuzma, P. Kacer (Prague, Czech Republic)

Source: Annual Congress 2008 - Occupational lung diseases
Session: Occupational lung diseases
Session type: Thematic Poster Session
Number: 3850
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Pelclova, Z. Fenclova, M. Krmencikova, T. Navratil, M. Kuzma, P. Kacer (Prague, Czech Republic). Levels of markers in blood and EBC in pneumoconioses. Eur Respir J 2008; 32: Suppl. 52, 3850

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Stability of sputum and blood eosinophil levels in COPD
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


Non invasive assessment of airway inflammation by exhaled markers in EBC, sputum and NO
Source: Eur Respir J 2004; 24: Suppl. 48, 578s
Year: 2004

Comparison of exhaled biomarkers to other markers of airway diseases
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 283s
Year: 2006

Blood eosinophil as a biomarker in COPD
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018


Role of blood neutrophilia as a biomarker in asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

Cytokines levels of blood and sputum in COPD exacerbation
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006

Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008


Comparison of leukotrienes in 3 matrices (EBC, blood and urine) in patients with pneumoconioses and control subjects
Source: Annual Congress 2010 - Mineral dusts and respiratory disease
Year: 2010


EBC markers in pneumoconioses at different ventilation rates
Source: Annual Congress 2008 - Inorganic dust exposure and the lung
Year: 2008


Associations between blood eosinophils and markers of nitric oxide pathway in blood and in exhaled breath condensate in asthmatics from the EGEA study
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010


Characteristic of cytokines levels of blood and sputum in COPD exacerbation
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011

Peroxidation processes, cytokines, BALF and blood cytology in patients with occupational lung diseases and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 275s
Year: 2002

The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Standardization of collection of exhaled breath condensate (EBC) for disease markers in use of different condensers
Source: Eur Respir J 2003; 22: Suppl. 45, 448s
Year: 2003